| Term 
 
        | Types of hormone treatments |  | Definition 
 
        | Aromatase inhibitors Antiandrogens
 Progestins
 SERMs and estrogen antagonists
 GnRH agonists and antagonists
 Adrenocortical hormones
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enzyme used to synthesize estrogen from androgen |  | 
        |  | 
        
        | Term 
 
        | Major site of estrogen synthesis in premenopausal women |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Estrogen synthesis is postmenopausal women |  | Definition 
 
        | Estrogens are synthesized from androstenedione in the adrenal gland and undergoes aromatization mainly in adipose tissue |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aromatase inhibitor used for the treatment of disseminated breast cancer in postmenopaulsal women 
 Reacts irreversibly with aromatase
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aromatase inhibitor devoid of androgenic activity that is used to treat disseminated breast cancer in postmenopausal women |  | 
        |  | 
        
        | Term 
 
        | 2 types of aromatase inhibitors |  | Definition 
 
        | 1) Based on steroidal nucleus 2) Non-steroidal inhibitors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonsteroidal aromatase inhibitors containing a triazole ring 
 Treats advanced breast cancer in postmenopausal women (not pre)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonsteroidal aromatase inhibitor for advanced and early stage breast cancer in posmenopausal women |  | 
        |  | 
        
        | Term 
 
        | Aminoglutethimide (Cytadren) |  | Definition 
 
        | Aromatase inhibitor used to treat advanced breast cancer (not as selective as others) 
 Also involves first step in the synthesis of adrenocortical steroid - the conversion of cholesterol to pregnenolone which is used to treat Cushing's Syndrome
 
 Treats Cushing's syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1) Flutamide 2) Nilutamide
 3) Bicalutamide
 
 They all inhibit translocation of the androgen receptor from the cytoplasm to the nucleus of target cells
 |  | 
        |  | 
        
        | Term 
 
        | Flutamide (Eulexin) Nilutamide (Nilandron)
 Bicalutamide (Casodex)
 |  | Definition 
 
        | Antiandrogen (anilid derivative) used in conjunction with GnRH analog for metastatic prostate cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1) Megestrol acetate (Megace) 2) Medroxyprogesterone acetate (Depo-Provera)
 |  | 
        |  | 
        
        | Term 
 
        | Megestrol acetate (Megace) Medroxyprogsterone acetate (Depo-Provera)
 |  | Definition 
 
        | Progestins used as second-line hormonal therapy for metastatic hormone-depdent breast cancer and management of endometrial carcinoma previously treated by surgery and radiotherapy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective estrogeneceptor modulators aka estrogen agonist/antagonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM that acts as estrogen agonists in bone, brain and liver but estrogen antagonists in the breast 
 Treatment of choice for postmenopausa women with ER+ metastatic breast cancer or following primary tumor therapy
 
 Also approved for long-term use in women with high risk of developing breast cancer
 
 However, have increased risk of endometrial cancer
 Reduce risk of CV disease in postmenopausal women
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM used in metastatic breast cancer in postmenopausal women with ER + or ER unknown tumors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM used for its antiresorptive effect on bone 
 Currently the subject of large study STAR (Study of Tamoxifen and Raloxifene) to prevent breast cancer
 
 Approved to reduce the risk of invasive breast cancer in postmenopausal women
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pure estrogen antagonist treat ER+ metastatic breast cancer in postmenopausal women who are resistant to tamoxifen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Produces LH and FSH which in turn cause gonads to synthesize and release androgens, progesterone, and estrogen 
 GnRH agonists will supress hormonal production through negative feedback
 |  | 
        |  | 
        
        | Term 
 
        | Leuprolide acetate (Lupron) |  | Definition 
 
        | GnRH agonists used in advanced prostate cancer** (Also endometriosis, uterine fibroids, central precocious puberty)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH initial administration causes an immediate and sustained release of LH and FSH 
 LH and FSH supression and reduction of androgenic and estrogenic effects after 10 days
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH antagonist used I.M to treat advanced prostate cancer 
 No initial flare-up but cause serious allergic reactions (Withdrawal from market in 2006)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH antagonist similar to abarelix but does not cause serious allergic reaction for Advanced prostate cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenocortical steroid which suppress mitosis in lymphocytes used to treat acute leukemia in children and malignant lymphoma in children and adults 
 Prednisone is preferred glucocorticoid
 |  | 
        |  |